A 50-year-old woman complains of oral pain; her dentist notes a mass along the undersurface of the tongue, extending onto the floor of mouth and refers her to an oral surgeon. She reports a 3 pack/day tobacco history since age 13, and drinks 2 shots of Bourbon and at least a six pack of beer/day. The oral surgeon palpates a mass in the floor of mouth fixed to the mandible (Figure 2a) . Biopsies of the lesion shows grade 3 squamous cell carcinoma (Figure 2b & c) . Palpation of the neck is unremarkable, and PET/CT confirms that the area of increased uptake is confined to the anterior tongue/floor of mouth lesion (Figure 2d & e) . A 40-year-old Chinese American man who reports he was born in a rural fishing village in southern China noted a painless lump in the right neck, nasal speech quality and sore throat. His physician noted that apparent tumor on the soft palate, ordered a contrasted enhanced CT of the neck, and referred him to an otolaryngologist. CT scan of the neck demonstrated a mass in the nasopharynx, invading the soft palate and protruding into the oropharynx (Figure 3a) . Adenopathy of the right upper neck and submandibular region was also identified (Figure 3b) . A fine needle aspirate of the submandibular node was performed, demonstrating malignant appearing squamous cells (Figure 3c 
Introduction
Head and neck cancers include cancers of the skin, thyroid and upper aerodigestive tract including the lip, oral cavity, oropharynx, nasopharynx, larynx, paranasal sinuses, salivary glands, and carcinomas of unknown primary origin found in cervical lymph nodes. Oncologists recognize the tremendous disparity in tumors collected under the rubric of "head and neck cancer" and appreciate that a full understanding of the malignancies in this category requires consideration of the characteristics of individual tumors.
This chapter focuses on cancers of the upper aerodigestive tract which are most often squamous cell carcinomas arising from the squamous epithelium that lines the tract. Overall though, these cancers are uncommon, accounting for only 3% of all malignancies in the United States (US). In 2018 64,700 new cases of oral cavity, oropharynx and larynx cancer will be diagnosed and 13,700 people are expected to die from this group of malignancies. (By comparison, 54,000 new cases of thyroid cancer and 234,000 new cases of lung cancer are expected.) Despite their heterogeneity, there are similarities in the therapeutic approaches to the different head and neck cancers. All modalities of anticancer treatment-surgery, radiation, and chemotherapy-are frequently employed against these cancers. In addition to cure, organ preservation is a major concern of treatment because of the integral function of the structures involved with these tumors. Given the complex issues involved in treatment, head and neck cancers provide a perfect example of the need for a multi-disciplinary approach to cancer and the invaluable role that tumor boards play in planning treatment.
This chapter is intended to provide an overview of head and neck cancers. Etiology, pathology, staging, and principles of treatment will be reviewed. Individual sites of cancer will be discussed only as examples to illustrate larger principles.
Etiology
In the US, head and neck cancers are strongly associated with tobacco use, including smoking, dipping, and chewing. Alcohol use is also strongly associated with these cancers, and the effect of tobacco and alcohol together is exponential, not simply additive, in increasing the risk for developing these cancers. Other organic substances that can come in contact with oral and nasal mucosal surfaces for long times (e.g., inhaled wood dust, the juice from betel nut chewing) are also known risk factors. All of these carcinogenic substances can bathe the epithelium throughout the mouth, nose, pharynx, and larynx and increase the risk of cancers developing at more than one site. This phenomenon is known as field cancerization.
Viruses also play a role. Oncogenic strains of human papilloma virus (HPV) (notably HPV 16) can cause head and neck cancers especially in the tonsils and the base of tongue (both part of the oropharynx). Cancers caused by HPV tend to arise in patients about 10 years sooner than non-HPV associated cancers and are less likely to arise in smokers and heavy drinkers. Interestingly, such cancers also tend to respond better to treatment and have a better prognosis than head and neck cancers not associated with HPV. The number of cases of HPV+ oropharyngeal cancers has been increasing rapidly in the United States, with the number of cases essentially doubling from1999 to 18,917 cases in 2015, when it was the most common HPV+ cancer in the United States. The rate of increase has been far greater in males than females; 82% of the HPV+ cancers occurred in men.
2. Epstein-Barr virus is associated with nasopharyngeal carcinoma.
Screening
Because head and neck cancer is so uncommon compared to other malignancies, patients and health care providers do not often think of this as the cause of a sore throat or an enlarged lymph node. Any patient with persistent sore throat, hoarseness, dysphagia (difficulty swallowing), odynophagia (painful swallowing) or enlarged cervical lymph node lasting more than three months should be referred to an otolaryngologist for evaluation. It is appropriate for the primary care provider to prescribe antibiotics or antireflux medications as initial therapy because most patients will suffer from routine ailments. However, longer lasting symptoms, especially in adults over 40 or in patients with a history of tobacco and/or alcohol use, should trigger referral to an otolaryngologisthead and neck surgeon for detailed physical exam. Of note, tobacco is also a strong risk factor for lung cancer, so anyone with head and neck squamous cell carcinoma (SCCA) in the setting of tobacco use should also undergo a chest X-ray as a basic screen for lung cancer.
Pathology
Most head and neck cancers arise from the epithelial lining, the most common histopathologic type being SCCA (Figure 4a and 4b). A significant exception to this is carcinomas of the salivary glands, which are frequently adenocarcinomas (Figure 5a and 5b). Minor and major salivary glands are scattered throughout the upper aerodigestive tract so the tumors arising in salivary glands must remain in the differential diagnosis along with less common malignancies such as mucosal melanomas (Figure 6a and 6b) while evaluating patients with head and neck cancers. 
Prognostic Factors
The stage of the cancer, the response to the initial treatment course and Human Immunodeficiency Virus (HIV) status are important prognostic factors. Advanced tumors, recurrent cancer and cancer in the setting of HIV positive serology all portend a worse prognosis. SCCA arising from HPV has a better prognosis than non-HPV SCCA. Immunosuppression after organ transplant is a very important prognostic factor for skin cancers.
Staging
Staging of head and neck cancers differs from many other solid tumors because of the propensity for these tumors to spread locally. Distant spread (e.g., to bones, lungs, liver, etc.) is less common than direct extension of tumors into adjacent structures. Similarly, death from these cancers is frequently due to complications from extensive tumor burden in the head, face, or neck. These complications include aspiration and malnutrition from an inability to swallow, and exsanguination from tumor erosion into an artery.
Since the extent of local disease is critical to staging, a good otolaryngology exam is mandatory, and is supplemented with diagnostic imaging. Endoscopy can provide direct visualization of the superficial mucosal detail of the tumor ( Figure 9a , the oral cavity is obscured by metallic streak artifacts from dental fillings and implants. Without the clinical information of an oral cavity lesion, the artifacts would have made detection of this squamous cell carcinoma more challenging and potentially missed by imaging alone. Figure 9b The current positron emitter used in PET, 18F-glucose, is readily taken up by many cancers of the head and neck, but also by inflammatory cells and the normal brain. Hence, it may be difficult at times to distinguish a lymph node involved with tumor from an inflamed lymph node on PET 3. (Figure  11c ). In this case a needle biopsy such as a fine needle aspiration (FNA) of the lymph node can be very helpful (Figure 12 ). As with any cancer patient, a distant metastatic workup must also be performed. Head and neck cancer, both SCCA and other histologic types, are most likely to spread first to regional lymph nodes, less commonly to the lungs and then to the liver and other sites.
The staging system currently used for many head and neck cancers is located here. Note that Stage IV disease can occur in the absence of distant spread of tumor. Either bulky cervical lymphadenopathy or tumor invasion into structures adjacent to the primary organ constitutes Stage IV disease, as does distant metastatic disease.
Principles of Treatment
Most head and neck cancers that have not spread beyond cervical lymph nodes are potentially cured with current treatments. However, once these cancers have spread into distant sites, such as lungs, bone, or liver, they are incurable and treatment is largely palliative. Current curative treatments will employ some combination of regional therapy using surgery and/or radiation, frequently with chemotherapy that is either given before radiation treatment ("induction" chemotherapy) or concurrent with radiation therapy One of the main principles of treatment is to minimize treatment modalities in an attempt to mitigate negative effects on function (i.e. utilizing surgical or non-surgical therapies alone to effect cure).
In addition to the goal of cure, another major treatment goal is preserving the functions of the structures involved by these tumors. Organ preservation protocols involving radiation +/-chemotherapy allow for anatomic preservation of structures within the upper aerodigestive tract. The function of these organs is rarely completely normal after radiation, but the majority of patients are able to breathe and swallow, keep their larynx and avoid permanent tracheostomy and gastrostomy tubes.
Currently, radiation or surgery appear to do equally well for most small (Stage I or II) head and neck tumors. In general, more extensive tumors are best treated with induction chemotherapy followed by concurrent chemotherapy and radiation with surgery reserved for tumors that do not achieve complete remission. An exception to this general rule are cancers of the oral cavity which have a better survival rate if surgery is performed first followed by radiation +/-chemotherapy.
Surgery
The goal of surgery is to completely remove all of the cancer while preserving as much uninvolved tissue as possible (Figure 13 ). Due to the confined anatomic region of the head and neck, margins are much closer than in other areas of the body and sacrifice of adjoining tissue can have a significant impact on patient function. In addition to surgical removal of the primary cancer, patients with higher stage tumors also require neck dissection to remove the lymph node beds that drain the primary site. In these cases, neck dissections are both therapeutic (by removing the lymph nodes) and staging (by establishing the extent of disease). However, recent data suggests that complete response (CR) on post treatment PET/CT scan of initially node positive head and neck cancer predicts excellent long-term disease free survival, and that neck dissection can be safely avoided in patients achieving CR. 4. Immediate reconstruction after cancer resection is of prime importance to allow patients to return to swallowing and speaking. Local, regional and distant free tissue flaps are essential components of the surgical care of many of these patients. Patients may require temporary tracheostomy and nasogastric feeding tubes as they heal from surgery, and fistulas caused by a breakdown in the pharynx with leakage of saliva into the neck are of special concern because they prohibit oral intake and delay healing.
Surgery can be used as solitary treatment of early stage cancer. In more advanced cases or if pathological evaluation reveals signs of more aggressive cancer (such as perineural or lymphovascular invasion), surgery is often followed by radiation therapy with or without chemotherapy to increase the chances for cure. Surgical salvage is used when patients have undergone nonsurgical treatment for their cancers but suffer from persistent or recurrent disease. Surgery in the post-radiation setting is associated with increased wound healing problems but does provide an effective cure in many cases.
Radiation Therapy
Radiation therapy (RT) may be used as a solitary treatment modality for early stage tumors or as first line therapy in combination with chemotherapy for more advanced disease. RT is also given after surgery when the primary tumor is large or has aggressive features or there are multiple lymph nodes involved with cancer. Radiation has the great advantage of organ preservation but does have some significant side effects like loss of salivary function, possible permanent lymphedema, possible radionecrosis of the mandible and permanent alteration in swallowing from scar tissue that may develop in the pharynx and neck musculature. Intensity Modulated Radiation Therapy (IMRT) allows for targeted delivery of radiation to the tumor site with smaller doses to the surrounding structures. This allows for greater preservation of salivary and swallowing functions that are essential to maintaining a good quality of life for head and neck cancer patients.
In general, RT lasts for 5-7 weeks depending on the stage of the cancer and whether the radiation is being given as first line therapy or in a postsurgical setting. Patients usually do not have many side effects the first four weeks of therapy. Fatigue, mucositis and other side effects may present toward the end of treatment and continue for several weeks after completion of RT.
RT for T1 true vocal cord cancer involves a tiny field encompassing only the larynx; for a T2 laryngeal cancer, only first echelon lymph nodes are treated. (Figure 14a & b) . While patients will have a sore throat during treatment, these treatments are usually very well tolerated. Late effects are largely restricted to voice changes, although professional singers have sometimes been able to return to professional singing after RT to the larynx. Treatment of large volumes (Figure 15 ) of the upper aerodigestive tract is much more difficult, with dry mouth, and loss of taste often interfering with hydration and nutrition. Some patients may require placement of a temporary feeding tube if they are unable to maintain oral intake and occasionally some patients require a tracheostomy tube because of airway edema. For those patients treated with radiation alone or in combination with chemotherapy, maintaining oral intake (even if a temporary feeding tube is necessary) is essential to preserving long-term swallowing function. Avoiding treatment breaks is essential for optimizing chance of cure, and adequate nutrition is a critical piece of the supportive care required to get patients through RT treatment. The most important late effect for patients' quality of life is severe dry mouth, which also can lead to issues with cavities and loss of teeth. For this reason, evaluation by a dentist or oral surgeon expert in the management of RT patients should occur as early in initial work-up as possible. The degree of dryness depends on the volume of remaining functional salivary gland tissue. IMRT permits sparing of, for example, the contralateral parotid gland (when possible), which significantly decreases severity of dry mouth (Figure 16 ). Except for early laryngeal cancer without lymph node metastases, IMRT has become standard of care for head and neck cancer treatment. 
Chemotherapy
Chemotherapy alone is not a mainstay for treatment of head and neck cancers but may be used in a solitary fashion for palliation of disease. The main role of chemotherapy is to sensitize the tissue to increase the effectiveness of radiation. Thus, it may be used as an initial treatment prior to radiation in the form of induction chemotherapy or simultaneous with radiation in the form of concurrent chemotherapy. Platinum-based drugs are most commonly used as sensitizing agents, but small-molecule inhibitors and monoclonal antibody agents also comprise an important role in certain head and neck cancer treatment protocols.
Outcome
Outcome is reported for each disease site separately, by stage. For example, 5-year relative survival rates for supraglottic cancer were 59.0% for localized disease, 53% for regional disease (positive lymph nodes, and 34% for distant disease (distant metastases) in 1995-96. True vocal cord cancer 5-year survival was 90% for Stage I disease, 74% for Stage II, 56% for Stage III disease, and 44% for Stage IV disease in the same period.
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And most of the T1 and T2 true vocal cord patients retained their larynx. Close follow-up by physicians trained in direct or at least indirect visualization of the larynx and physical examination of the head and neck is very important, as regional recurrences may be salvaged for long term disease-free survival if the recurrences are found early. But locally advanced recurrences are almost always treated with palliative intent (Figure 17 ). 
Conclusion
Cancers of the upper aerodigestive tract are most often SCC. Tobacco and alcohol are the leading causes; recently an epidemic of HPV cancers, particularly of the oropharynx has developed. It is hoped that HPV vaccination may decrease the incidence of this disease in the future.
Management of these cancers requires a full multidisciplinary team: otolaryngologist, radiation oncologist, medical oncologist, diagnostic radiologist, qualified dentist/oral surgeon, nutritionist and social worker at a minimum. While these cancers, especially the HPV+ ones, appear in patients from all walks of life and economic statuses, the importance of tobacco and especially alcohol in the lives of many patients means that their life situations are often very complicated, requiring considerable social support during treatment.
The fact that these cancers are less likely to spread beyond the neck means that even very advanced malignancies are often curable, so late effects are an important consideration in treatment decisions. And many of these patients will live to experience second, third and fourth cancers of the aerodigestive tract. 
Thought Questions

Expert Answer
The most likely diagnosis is HPV-associated SCCA of the left tonsil or base of tongue that has metastasized to a regional lymph node.
HPV has been strongly associated with cervical cancer and can be transmitted through sexual activity. In a patient of relatively young age with these symptoms, he is very likely to have this type of cancer. An infectious process like streptococcus would more likely involve both sides of the throat and any associated lymphadenopathy would present within a few days of the infection rather than weeks later. This patient should be referred to an otolaryngologist-head and neck surgeon for complete evaluation. Prescribing a course of antibiotics is not contraindicated but follow up should be rapid to ensure there is no delay in diagnosis.
Maintain oral intake even if a temporary feeding tube is necessary.
Some patients develop such significant mucositis or impairment of their pharyngeal musculature that it is very difficult for them to continue eating and drinking while undergoing radiation. Patients may require a nasogastric tube to avoid dehydration and significant weight loss. However, the key to long term swallowing function is to maintain oral intake, even if most nutrition is temporarily provided via non-oral means.
The best option is to pursue radiation therapy as first line therapy.
Since the patient must receive radiation, it is better for his functional status if he is treated for cure with radiation. His functional status will be lower if he is treated with multiple modalities. When cure rates are similar between modalities, it is best to pursue only one type of treatment. Surgery alone or radiation alone better preserve tissue function more than surgery with radiation because of their additive adverse effects.
Glossary
Aerodigestive tract-The oral and nasal cavities and throat, and some people include the trachea and esophagus, through which air, food and liquids pass Exsanguination-Severe blood loss, sufficient to cause death Field cancerization-Atypia ranging from mild abnormality to invasive cancer that affects a wide area of an anatomic region usually involving multiple sites to various degrees Transglottic-A cancer which involves both false cord and true vocal cord, extending through the laryngeal ventricle.
